Paul R. Kirchgraber, CEO, Covance Drug Development: Labcorp Holdings LH Sell · Filed 23/05/23

Trade details

Type: Insider sale
Amount: $932,713
Shares · price: 4,300 sh · $216.91 a share
Held after: 12,946 sh
Stock: Labcorp Holdings LH
Person: Paul R. KirchgraberCEO, Covance Drug Development
Trade date: 23/05/19
Filed: 23/05/23
Days to filing: 4 days

Sold 24.9% of holdings

Share of holding sold: 24.9%

Labcorp Holdings trades, last 26 weeks

What else happened in Labcorp Holdings around then

Filed or reported within 30 days of the trade day · 23/04/19~23/06/18

Paul R. Kirchgraber's recent trades

Paul R. KirchgraberCEO, Covance Drug Development
SellLabcorp Holdings
Sell
Labcorp Holdings
LH
$2M
8,000 sh
$2M
Filed 23/02/23
Traded 23/02/21